Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · Real-Time Price · USD
12.42
-0.03 (-0.24%)
Jan 23, 2025, 12:29 PM EST - Market open
Avid Bioservices Revenue
Avid Bioservices had revenue of $33.48M in the quarter ending October 31, 2024, with 31.84% growth. This brings the company's revenue in the last twelve months to $150.45M, up 6.75% year-over-year. In the fiscal year ending April 30, 2024, Avid Bioservices had annual revenue of $139.91M, down -6.27%.
Revenue (ttm)
$150.45M
Revenue Growth
+6.75%
P/S Ratio
5.26
Revenue / Employee
$405,512
Employees
371
Market Cap
793.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 139.91M | -9.36M | -6.27% |
Apr 30, 2023 | 149.27M | 29.67M | 24.81% |
Apr 30, 2022 | 119.60M | 23.73M | 24.75% |
Apr 30, 2021 | 95.87M | 36.17M | 60.58% |
Apr 30, 2020 | 59.70M | 6.10M | 11.38% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
CDMO News
- 20 hours ago - Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand - GlobeNewsWire
- 23 hours ago - The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Avid Bioservices, Inc. For Securities Fraud - Accesswire
- 2 days ago - Avid Bioservices, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 3 days ago - The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Avid Bioservices, Inc. For Securities Fraud - Accesswire
- 8 days ago - Avid Bioservices Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Avid Bioservices, Inc. (CDMO) Shareholders to Inquire about Securities Investigation - Accesswire
- 10 days ago - Avid Bioservices Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Avid Bioservices, Inc. (CDMO) And Encourages Shareholders to Connect - Accesswire